This is a preview of subscription content, log in via an institution to check access.
Notes
Center for Food Safety and Applied Nutrition, Center for Drug Evaluation and Research, Center for Devices and Radiological Health, and Center for Biologics Evaluation and Research.
Reference
US Food and Drug Administration. Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic. Internet Document : 11 May 2020. Available from: URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/postmarketing-adverse-event-reporting-medical-products-and-dietary-supplements-during-pandemic
Rights and permissions
About this article
Cite this article
US guidance issued for postmarketing AE reporting during pandemic. Reactions Weekly 1805, 2 (2020). https://doi.org/10.1007/s40278-020-78712-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78712-z